Blastic plasmacytoid dendritic cell neoplasm (BPDCN) was previously referred to as natural killer (NK) cell leukemia/lymphoma. As understanding of the biology and origin of this malignancy has improved, the planet Health Organization (WHO) established the term blastic plasmacytoid dendritic cell neoplasm (BPDCN) in 2008. The diagnosis is challenging, since neoplastic cells can resemble lymphoblasts or small immunoblasts, and need the utilization of an outsized panel of antibodies, including those against CD4, CD56, CD123, CD303, TCL1, and TCF4. The morphologic and partially phenotypic ambiguity explains the uncertainties on the histogenesis of the neoplasm that led to the utilization of varied denominations. Recently, a series of molecular studies supported karyotyping, organic phenomenon profiling, and next generation sequencing, have largely unveiled the pathobiology of the tumour and proposed the doubtless beneficial use of latest drugs.
Short Communication: Fluid Mechanics: Open Access
Short Communication: Fluid Mechanics: Open Access
Short Communication: Fluid Mechanics: Open Access
Short Communication: Fluid Mechanics: Open Access
Research Article: Fluid Mechanics: Open Access
Research Article: Fluid Mechanics: Open Access
Perspective: Fluid Mechanics: Open Access
Perspective: Fluid Mechanics: Open Access
Short Communication: Fluid Mechanics: Open Access
Short Communication: Fluid Mechanics: Open Access
Scientific Tracks Abstracts: Journal of Lasers, Optics & Photonics
Scientific Tracks Abstracts: Journal of Lasers, Optics & Photonics
Scientific Tracks Abstracts: Journal of Lasers, Optics & Photonics
Scientific Tracks Abstracts: Journal of Lasers, Optics & Photonics
Posters & Accepted Abstracts: Journal of Lasers, Optics & Photonics
Posters & Accepted Abstracts: Journal of Lasers, Optics & Photonics
Fluid Mechanics: Open Access received 291 citations as per Google Scholar report